Search results
Author(s):
Cynthia A James
Added:
3 years ago
Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) is a rare heritable cardiomyopathy characterised by fibro-fatty replacement of the myocardium, which predisposes patients to frequent lifethreatening ventricular arrhythmias and slowly progressive ventricular dysfunction.1,2 Structural involvement of the right ventricle (RV) generally predominates,3,4 although left dominant forms…
View more
Mimics of Hypertrophic Cardiomyopathy - Diagnostic Clues to Aid Early Identification of Phenocopies
Author(s):
Rajiv Sankaranarayanan
,
Eleanor J Fleming
,
Clifford J Garratt
Added:
3 years ago
Article
Author(s):
Ling Kuo
,
Jackson J Liang
,
Saman Nazarian
,
et al
Added:
3 years ago
Catheter ablation has been increasingly used as a treatment for refractory ventricular tachycardia (VT) in patients with non-ischaemic cardiomyopathy (NICM). However, ablation outcomes tend to be quite variable because of the heterogeneity of the aetiology for the NICM and associated VT substrate in these patients.1–3 Patients with NICM can be sub-classified based on specific genotypic and…
View more
Author(s):
Roland R Tilz
,
Charlotte Eitel
,
Evgeny Lyan
,
et al
Added:
3 years ago
Ventricular tachycardia (VT) is associated with increased mortality in patients with a history of MI. ICD implantation is currently the standard of care for the prevention of sudden cardiac death, and contributes to a reduction of total mortality.1 Despite effective treatment of ventricular arrhythmias with the use of anti-tachycardia pacing (ATP) or shocks, ICDs do not prevent VT. Furthermore,…
View more
The Role of Cardiac MRI in the Diagnosis and Risk Stratification of Hypertrophic Cardiomyopathy
Author(s):
Ethan J Rowin
,
Martin S Maron
Added:
3 years ago
Article
Author(s):
Roland R Tilz
,
Charlotte Eitel
,
Evgeny Lyan
,
et al
Added:
3 years ago
In the article by Tilz et al. entitled “Preventive Ventricular Tachycardia Ablation in Patients With Ischaemic Cardiomyopathy: Meta-analysis of Randomised Trials” (Arrhythmia & Electrophysiology Review 2019;8(3):173–9. https://doi.org/10.15420/aer.2019.31.3), the following correction should be made:
The authors acknowledge that Prof Tilz and Dr Eitel contributed equally as first authors to this…
View more
Author(s):
Tom Nelson
,
Pankaj Garg
,
Richard H Clayton
,
et al
Added:
3 years ago
Ventricular tachycardia (VT) and VF occur mainly in people with impaired cardiac function and/or ischaemic heart disease, and account for the majority of sudden cardiac deaths worldwide.1 Treatment with anti-arrhythmic drugs such as amiodarone may be at best neutral in terms of mortality and carries significant long-term risks.2,3 While ICDs significantly improve survival for patients with…
View more
Author(s):
Jan Mizner
,
Pavel Jurak
,
Hana Linkova
,
et al
Added:
1 year ago
Author(s):
Laurent Roten
,
Matthew Daly
,
Patrizio Pascale
,
et al
Added:
3 years ago
With an ageing population and widespread use of implantable cardioverter-defibrillators, physicians are confronted with an increasing number of patients with symptomatic, drug-refractory ventricular tachycardia (VT). Catheter ablation is an important treatment option in the management of patients with structural heart disease and VT.1,2 In many patients, VT can be successfully ablated from the…
View more
Martin S Maron
Research Area(s) / Expertise:
Author